Clinical Trials for Ankyra Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ankyra Therapeutics

Clinical Trials (3)

NCT07100925
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
PHASE1Not yet recruiting
20 participants
Started: Dec 15, 2025 · Completed: Dec 31, 2030
4 conditions1 sponsor0 locations
NCT07027514
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
PHASE1Recruiting
60 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06171750
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
PHASE1Recruiting
97 participants
Started: Jan 19, 2024 · Completed: Jun 30, 2027
9 conditions1 sponsor5 locations